Hermine O, Gros L, Tran TA, Loussaief L, et al. Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease. PLoS One 2025;20:e0322199.
PMID: 40367050